Quite a few insiders have dramatically grown their holdings in Cogstate Limited (ASX:CGS) over the past 12 months. An insider's optimism about the company's prospects is a positive sign. While we ...

A look at the shareholders of Cogstate Limited (ASX:CGS) can tell us which group is most powerful. Institutions will often hold stock in bigger companies, and we expect to see insiders owning a ...

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an eye out for. One common approach is to try and find a company with returns on ...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? Firstly, we'd want to identify a growing return on capital employed (ROCE) and ...

Good morning, everyone. Welcome to Cogstate's Full Year Results for Financial Year '25. I'm pleased to introduce on our call today, Brad O'Connor, Cogstate CEO and Managing Director; Darren Watson, ...

Japanese pharma Eisai is boosting its 2019 pact with Australian medtech firm Cogstate and its cognitive function test. The original pact, penned last August, was a development and sales deal centered ...

Cogstate Ltd (AU:CGS) has released an update. Cogstate Ltd has announced a partnership with Medidata to deliver a unified solution for central nervous system disease assessments, marking a significant ...

NEW HAVEN, Conn.--(BUSINESS WIRE)--The cognitive science company, Cogstate Ltd (ASX:CGS) today announced a presentation entitled, “Methodology for Development of Indication-Specific Outcome Measures ...

The average one-year price target for COGSTATE (ASX:CGS) has been revised to 1.89 / share. This is an increase of 10.78% from the prior estimate of 1.70 dated October 4, 2023. The price target is an ...

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...

BOSTON--(BUSINESS WIRE)--The cognitive science company, Cogstate, today announced that its Healthcare Division has received CE Mark approval for its Cognigram TM digital cognitive assessment system.

The Cogstate Limited (ASX: CGS) share price has rocketed more than 78% higher in early trade after the company released its quarterly cash flow statement. You’re reading a free article with opinions ...